Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.3600
-0.0100 (-2.70%)
Aug 28, 2025, 3:59 PM EDT
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$768,800
Profits / Employee
-$539,448
Market Cap
89.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | 28 | 14 | 100.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 68 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
Vaxart News
- 8 days ago - Concerned Vaxart Stockholders Unite to Oppose Vaxart's Latest Reverse Stock Split and Defend Stockholder Rights - GlobeNewsWire
- 15 days ago - Vaxart outlines accelerated COVID-19 trial data timeline and plans norovirus Phase IIb pending funding - Seeking Alpha
- 15 days ago - Vaxart, Inc. (VXRT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - US orders Vaxart to stop COVID-19 trial amid mRNA wind down - Reuters
- 16 days ago - Vaxart Revenue Jumps 520% in Fiscal Q2 - The Motley Fool
- 17 days ago - Vaxart's Earnings: A Preview - Benzinga
- 5 weeks ago - Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq - GlobeNewsWire
- 2 months ago - Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - GlobeNewsWire